2020 OCT 15 Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)

GOOGLE A Serious Violators of the 1st Amendment
FACEBOOK A Serious Violators of the 1st Amendment
YOUTUBE A Serious Violators of the 1st Amendment
TWITTER A Serious Violators of the 1st Amendment
4CM_Telegram-thumbs-up-400w-480h.fw
Internet_Archive_thumbs-up-400w-480h.fw
bitchute-thumbs-up-400w-480h.fw
Gab_thumbs-up-400w-480h.fw
parler-thumbs-up-400w-480h.fw

Remarks: Of those that took HCQ before getting to hospital the death rate was reduced to 10.5%. Those that didn’t get HCQ before they got to hospital 29.5% died. To those who have lobbied against HCQ because you want to profit from other treatments – hell awaits you, you’ve committed crimes against humanity. To those useful idiots of the left, that have aided and abetted these crimes because of your TDS, you have blood on your hands. FULL STORY HERE: https://www.4cmitv.com/2020/10/16/2020-oct-15-clinical-characteristics-and-outcomes-among-hospitalized-adults-with-severe-covid-19-admitted-to-a-tertiary-medical-center-and-receiving-antiviral-antimalarials-glucocorticoids-or-immun/

The Fourcm (4cm) Group: 4cminewswire.com  4cmitv.com  4cminews.com  fourcm.net
4cm Social Media: PARLER @Gary4cm  GAB @4cminewsire TWITTER: @4cmtvworld TWITTER: @4cminews YOUTUBE: @GaryGreen4CMiCTV BITCHUTE: @Freedom4CM

CRAIG KELLY MP HEADLINES: Latest Peer-Reviewed Hydroxychloroquine Published Study

Look at the data. Look at the numbers. Just imagine if you had a family member in this study that was denied HCQ.

To those who have lobbied against HCQ because you want to profit from other treatments – hell awaits you, you’ve committed crimes against humanity.

To those useful idiots of the left, that have aided and abetted these crimes because of your TDS, you have blood on your hands.

source https://www.sciencedirect.com/science/article/pii/S2589537020303357

This was a retrospective, single-center, observational study, with data on adult patients admitted to Hospital Universitario Quironsalud Madrid.

The results found:

flag 2 icon 

Of those NOT administered any HCQ either before or after hospitalisation 42.4% died.

Those that received HCQ in hospital 26.4% died.

flag 2 icon

Of those that took HCQ before getting to hospital the death rate was reduced to 10.5%.

Those that didn’t get HCQ before they got to hospital 29.5% died.

bulb icon

On these numbers, would do we say to individuals that have taken active steps to deny people access to HCQ ? 

ORIGINAL SOURCE: Date-stamped: 2020 OCT 16 | Author: Craig Kelly MP  Article Title: LATEST PEER-REVIEWED HYDROXYCHLOROQUINE PUBLISHED STUDY | Article Link: CraigKellyMP 

FILE SIZE: 2 mb

PAGES: 10

DOWNLOAD PDF:

1-s2.0-S2589537020303357-main

Hashtags: #4cminewswire, #HCQ, #Hydroxychloroquine, #COVID19, #4cminews, #4CMiTV, #4CM2020OCT15,

Tags: 4cminewswire, HCQ, Hydroxychloroquine, COVID-19, 4cminews, 4CMiTV, #4CM2020OCT15,




SOURCE ACKNOWLEDGEMENTS
Original-Source: Science Direct
Original-Source-Published: 2020 OCT 15
Original-Source-URL: sciencedirect.com


Leave a Reply

Your email address will not be published. Required fields are marked *